PolySon™ T is a preclinical ultrasound contrast agent comprising microbubbles optimized for tumor imaging. Its high echogenicity and prolonged circulation time enhance visualization of vascularized tumors in animal models, enabling detailed assessment of tumor vasculature.
PolySon™ T supports detection and monitoring of tumors, evaluation of tumor progression, and assessment of therapeutic efficacy in preclinical studies. The agent is particularly suitable for longitudinal studies requiring repeated imaging sessions.
The microbubbles have a number-weighted particle size of 1-3 µm, providing robust contrast at standard ultrasound frequencies. Long blood half-life ensures a broad imaging window for dynamic studies.
PolySon™ T offers consistent and high-contrast imaging of tumor vasculature, facilitating precise monitoring of tumor development and response to interventions. Its design allows enhanced visualization in highly vascularized lesions.
Contrast-enhanced ultrasound (CEUS) of HBV-transgenic mouse liver demonstrates rapid and sustained enhancement of hepatocellular carcinoma nodules. PolySon™ T enables accurate identification and temporal monitoring of tumor vascularization.
PolySon™ T is available in single and multiple injection packs. Ordering through an authorized distributor ensures local availability, technical support, and guidance for preclinical tumor imaging protocols.
Authorized distributor of Viscover products by Nanopet Pharma GmbH. This page contains original distributor-specific content for preclinical ultrasound tumor imaging using PolySon™ T.
Price range: USD $551 through USD $2,546
